AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01787045 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Passive Range of Motion
Description: Passive mobilization will be performed in all limbs as 10 repetitions of every range of motions. Extension position will be maintained for some seconds to attaint muscular elongation in every muscular group.
Study NCT01787045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive Range of Motion
Description: Passive mobilization will be performed in all limbs as 10 repetitions of every range of motions. Extension position will be maintained for some seconds to attaint muscular elongation in every muscular group.
Study NCT01462591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-citrulline
Description: 2 weeks of L-citrulline supplementation (100mg/kg of body weight).
Study NCT01462591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: L-citrulline
Description: 2 weeks of L-citrulline supplementation (100mg/kg of body weight).
Study NCT00693420 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% sterile solution
Description: Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily.
Study NCT00693420 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: vehicle sterile solution
Description: Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily
Study NCT03849196 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bisacodyl 10Mg Suppository
Description: bisacodyl 10 mg suppository
Study NCT03849196 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1L PEG-Asc
Description: PEG-Asc powder
Study NCT02063620 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine HCL
Description: ketamine HCL is using as adjuvant agent with local anesthetic agent in regional intravenous anesthesia procedure routinely
Study NCT03932890 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Patient controlled fluid device administering high volume thirst guided fluid bolus
Description: The administration of a 200ml fluid bolus in response to subjective thirst. Participant activates trigger in response to thirst which activates fluid pump to deliver 50ml IV fluid bolus of 4% dextrose \& 0.18% sodium chloride
Study NCT03932890 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patient controlled fluid device administering low volume thirst guided fluid bolus
Description: The administration of a 50ml fluid bolus in response to subjective thirst. Participant activates trigger in response to thirst which activates fluid pump to deliver 50ml IV fluid bolus of 4% dextrose \& 0.18% sodium chloride
Study NCT04246268 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INVOcell
Description: Female participants undergoing in vitro fertilization (IVF) and/or Intracytoplasmic Sperm Injection (ICSI) for assisted reproduction will be asked to participate.
Study NCT03338452 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low energy ketogenic diet
Description: Low energy ketogenic diet lasting 12 weeks with a previous preparation period including detailed instructions during classes and individual counselling by a dietitian. Participants were provided with a list of suitable foods with very low carbohydrate content. Furthermore, the subjects shared cooking recipes and links to helpful webpages. They were free to follow a KD according to their personal preferences but limit their carbohydrate intake to 5-10 % of total energy from carbohydrates, but derive at least 70 % of total energy from fat.
Study NCT01644019 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Teleconsultation
Description: Teleconsultation of an EMS physician in cases of suspected acute stroke
Study NCT03144089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Articulated Oral Airway
Description: The AOA is a novel device which actively displaces the tongue, allowing for a greater cross-sectional area for mask ventilation. The AOA will be evaluated for efficacy of mask ventilation.
Study NCT03144089 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Guedel oral airway (active comparator)
Description: The Guedel oral airway is a standard oral airway commonly used to facilitate mask ventilation. The Guedel oral airway will be evaluated for efficacy of mask ventilation.
Study NCT03669146 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glasses
Description: Partial refractive correction in a pair of glasses.
Study NCT03669146 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Glasses
Description: Partial refractive correction in a pair of glasses.
Study NCT01784250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clonidine
Description: Clonidine 150 mcg tablet single dose, to receive by mouth one hour before surgery
Study NCT01091649 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ABT-450
Description: High dose ABT-450 / ritonavir See Arm Description for more information
Study NCT01784250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Propranolol 40 mg tablet single dose, to receive by mouth one hour before surgery
Study NCT01784250 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill manufactured to mimic a drug
Study NCT04197206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: costotransverse block
Description: patient controlled analgesia devices with tramadol
Study NCT05563259 — intervention group
Intervention type: RADIATION
Intervention: Cognitive assessment, functional magnetic resonance imaging
Description: Our study investigated cognitive function, MRI measures of brain structure and activation in patients undergoing liver biopsy. We aimed to evaluate the changes of cognition during the process of NAFLD and explore the association between brain alterations and cognition.
Study NCT01711437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEG-4000 with citrates and simethicone
Description: 1-4 bisacodyl 5-mg tablets (Lovoldyl) at 16:00, followed 2-3 hours later by 50 ml/kg (maximum 2 L) of PEG-CS solution. The patients were instructed to drink all solution in about 2-3 hours.
Study NCT01711437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: polyethylene glycol 4000 solution with simethicon
Description: patients received a polyethylene glycol 4000 solution with simethicon (Selg Esse) starting at 3:00 p.m. the day before the colonoscopy at a dose of 100 ml/Kg (maximum 4 L). The patients were instructed to drink all solution in about 4-6 hours.
Study NCT01711437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid
Description: patients received a polyethylene glycol 3350 hyper-osmotic solution with ascorbic acid (Moviprep) a dose of 50 ml/Kg (maximum 2 L) with 25 ml/kg additional clear fluid after completing solution intake.
Study NCT00756405 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Antioxidant diet
Description: Participants were asked to increase antioxidant-rich food intake to approximately double their daily habitual intake and take a placebo pill.
Study NCT00756405 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Antioxidant supplement
Description: Participants were asked to consume their usual diet and take a supplement containing carotenoids, mixed tocopherols, vitamin C and selenium, designed to approximately double their daily habitual intake.
Study NCT00756405 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Participants were asked to consume their usual diet and take a placebo pill.
Study NCT00756405 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants were asked to consume their usual diet and take a placebo pill.
Study NCT04926519 — intervention group
Intervention type: OTHER
Intervention: Type of periodontal treatment
Description: Identify factors that contribute to disease recurrence due to periodontal classification and periodontal treatment. One group have got the diagnosis aggressive periodontitis at baseline and the other group chronic periodontitis. Since 2018 we have the classification system with stage and grade.
Study NCT01711437 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sodium picosulphate plus magnesium oxide and citric acid
Description: patients received two sachets of sodium picosulphate plus magnesium oxide and citric acid (Picoprep), each diluted in 150 ml of water, at 14:00 and 6 hours later in the evening prior to the colonoscopy. Intake of at least 40-50 ml/kg of clear fluids
Study NCT00649610 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: valdecoxib
Description: valdecoxib 40 mg QD for 7 days with a second dose of 40 mg the first day
Study NCT00649610 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: diclofenac
Description: diclofenac 75 mg twice daily (BID) for 7 days
Study NCT05283499 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OPIOID
Description: Analgesic assignment
Study NCT05283499 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NON-OPIOID
Description: Analgesic assignment
Study NCT04722289 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Together on Diabetes
Description: Social and emotional support'; 'Assistance in daily management'; and 'Linkage to healthcare services'
Study NCT01464398 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress reduction
Description: 8 weekly sessions
Study NCT01464398 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress reduction with Health education
Description: 8 weekly sessions
Study NCT00169767 — intervention group
Intervention type: OTHER
Intervention: Comparison study between KTP and HoLAP for BPH
Description: Comparison study between KTP and HoLAp for BPH
Study NCT03908268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Description: The mother-child pair will be asked to talk and play with each other as the pair customarily does. If the child becomes restless and dysregulated, the mother will be coached by the Nurture Specialist to bring the child back into a calm state through sustained physical contact, comforting touch, soothing words and eye contact. Each dyad will attend eight group FNI sessions within sixteen weeks.
Study NCT03908268 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Children's Learning Center (CLC) Program
Description: Typical, age-tailored CLC curriculum taught by CLC teachers. Children attend CLC as usual and parents do not take part in group sessions.
Study NCT05732597 — intervention group
Intervention type: PROCEDURE
Intervention: Coronary angiography
Description: A coronary angiogram is a procedure that uses X-ray imaging to see the patient's blood vessels of the heart. The test is generally done to see if there's a restriction in blood flow going to the heart.
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: non-encapsulated FeSO4
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: encapsulated FeSO4, before cooking
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: encapsulated FeSO4, after cooking
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: non-encapsulated FeSO4 + ascorbic acid
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: encapsulated FeSO4 + ascorbic acid, before cooking
Study NCT02353325 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: encapsulated FeSO4 + ascorbic acid, after cooking
Study NCT01381224 — intervention group
Intervention type: OTHER
Intervention: Observation of biomechanical effects post injection
Description: Observation of effects on gait, lumbar spine range of motion and pain symptoms immediately following injection and at two weeks post injection
Study NCT03149302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local neck treatment (LNT)
Description: The local neck treatment consists of cervical mobilization and specific therapeutic exercises (30 minutes). The participants will attend 12 individual treatment sessions (2 visits per week for 6 weeks).
Study NCT03149302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LNT plus sensorimotor exercises
Description: The local neck treatment (30 minutes) plus the sensorimotor exercise program (15 minutes). The sensorimotor exercises include cervical joint position sense and oculomotor training. The participants will attend 12 individual treatment sessions (2 visits per week for 6 weeks).
Study NCT03149302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LNT plus balance exercises
Description: The local neck treatment (30 minutes) plus the balance exercise program (15 minutes).The balance program includes with static balance and progress to dynamic balance and gait. The participants will attend 12 individual treatment sessions (2 visits per week for 6 weeks).
Study NCT03149302 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LNT plus sensorimotor/balance exercises
Description: The local neck treatment (30 minutes) plus the sensorimotor exercise program (15 minutes) and the balance exercises (15 minutes). The participants will attend 12 individual treatment sessions (2 visits per week for 6 weeks).
Study NCT02652442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Centrifugation Distance
Description: To determine optimal distance off-axis, participants were rotated in a darkened rotary chair booth with 1 ear positioned 3.5 cm off-axis and the other ear positioned on-axis for 1 minute. Participants received 5 sessions in a 1-week period. Following a 2-week washout period, participants were rotated in a darkened rotary chair booth with 1 ear positioned 7.0 cm off-axis and the other ear positioned on-axis for 1 minute. Participants received 5 sessions in a 1-week period.
Study NCT02652442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Centrifugation Duration
Description: To determine optimal duration, after a two week washout period, participants were rotated off-axis at 3.5 cm (determined to be optimal in Exp 1) for 3 minutes. Participants received 5 sessions in a 1-week period.
Study NCT03328195 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuro RX Gamma synchronous
Description: Twenty minute treatment, six days per week for 12 weeks
Study NCT03328195 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Twenty minutes, six days per week for 12 weeks with sham device
Study NCT02652442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Centrifugation Schedule
Description: To determine optimal schedule, after a two week washout period, participants were rotated off-axis at 3.5 cm (determined to be optimal in Exp 1) for 3 minutes (determined to be optimal in Exp 2). Participants received biweekly sessions for a total of 5 sessions.
Study NCT02984332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower limb immobilisation (leg brace)
Study NCT04124185 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ocular assessments
Description: Complete ocular examination, Axial length and corneal curvature, Optical Coherence Tomography, Visual acuity, Contrast sensitivity
Study NCT01540318 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Abdominal Ultrasound (FAST examination)
Description: Use of FAST abdominal ultrasound exam
Study NCT04072328 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol will be given 0.5 mg/kg bolus initially, and can be administered additionally after a least 30 secs if necessary.
Study NCT04072328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol will be given 0.5 mg/kg bolus initially, and can be administered additionally after a least 30 secs if necessary.
Study NCT04072328 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: midazolam with propofol
Study NCT03148652 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Enhanced Intervention Condition
Description: The intervention incorporates 1) a standard, evidence-based cognitive behavioral therapy-based smoking cessation program, 2) working memory training, and 3) a motivational enhancement component. Working memory training will be administered via the computerized program Cogmed QM. Investigators will be able to monitor participants' progress throughout the study, using the data that the program gathers.
Study NCT03148652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention Condition
Description: The intervention incorporates 1) a standard, evidence-based cognitive behavioral therapy-based smoking cessation program, 2) working memory training, and 3) a motivational enhancement component. Working memory training will be administered via the computerized program Cogmed QM. Investigators will be able to monitor participants' progress throughout the study, using the data that the program gathers.
Study NCT02257112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multistage low-energy stimulation
Description: The parameters of the Multistage waveform will be altered and the response of the atria will be recorded.
Study NCT00666055 — intervention group
Intervention type: DRUG
Intervention: ARV regimen chosen by treating physician
Description: Women may also be naïve to either NNRTI or PIs and initiating their first, second or third HAART regimen (ARVs to be investigated: zidovudine, lamivudine, emtricitabine, abacavir, tenofovir, efavirenz, lopinavir/ritonavir, atazanavir with or without ritonavir).~Provided the ARV regimens contain one or more of the agents under study they may also include new agents such as maraviroc (CCR5 inhibitor), raltegravir (integrase inhibitor) and/or etravirine (NNRTI).
Study NCT01167088 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoquinone mesylate
Description: 2 tablets to be taken daily upon wakening, with a glass of water and at least one hour before food.
Study NCT01167088 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT00883649 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Hydroeye
Description: 2 Capsules BID
Study NCT01970007 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zilver Vena Venous Self-Expanding Stent
Description: stenting
Study NCT03328195 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuro RX Gamma asynchronous
Description: Twenty minutes, six days per week for 12 weeks with sham device
Study NCT01794897 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: Valacyclovir treatment
Description: Patients will have a placebo run-in for two weeks after which they will be evaluated for the variables of interest and then randomized to either VAV or placebo group in a 1:1 proportion. The VAV group will receive 1.5 g Valacyclovir by mouth, twice daily for 16 weeks, after which they will be followed up without VAV for 4 weeks to monitor delayed adverse effects.
Study NCT00883649 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Inactive Capsule
Description: 2 Capsules BID
Study NCT01979380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KD101
Description: 200mg (1casule), 600mg (3 capsule), 1000mg (5 capsule), 1400mg (7 capsule) PO, once in the morning
Study NCT01979380 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: PO, once in the morning
Study NCT01562197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: axitinib
Description: The starting dose of axitinib (AG-013736) is 5 mg BID administered orally with food.
Study NCT01562197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib plus Lomustine
Description: Lomustine 90mg/m²
Study NCT00923962 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucagon like peptide-1
Description: 0,1 pmol/kg/min
Study NCT00923962 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adenosine
Description: 20-40 microgram/minute
Study NCT04556929 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Intra-operative imaging of 5-ALA fluorescence using ultra-high sensitivity camera
Description: An ultra-high sensitivity camera attached to the side arm of the operative microscope will be used to take images of the anterior, posterior, lateral and inferior walls of the resection cavity on completion of tumour resection.
Study NCT04556929 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Intra-operative imaging of 5-ALA fluorescence using in-built operative microscope camera
Description: In-built camera of the operative microscope will be used to take images of the anterior, posterior, lateral and inferior walls of the resection cavity on completion of tumour resection.
Study NCT04556929 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Biopsies
Description: Following image capture, biopsies (approx 5x5x5mm size) will be taken from regions of the anterior, posterior, lateral and inferior walls of the resection cavity corresponding to the imaged areas.
Study NCT04471168 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryo-Auriculotherapy
Description: 3 sessions of cryo-auriculotherapy with device with nitrous oxyde on 10 auricular points at one month intervals.
Study NCT04471168 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: 3 sessions of cryo-auriculotherapy with device without nitrous oxyde on 10 auricular points at one month intervals.